M. Nahid Parvin holds a PhD in Physiology from the University of Tokushima (Japan), in the field of cell membrane biology. She did her post doc on membrane biology at NIDCR, National institute of health and on Gene Therapy products at Gene Therapy and Therapeutic Branch, Center for Biologics Evaluation and Research (CBER), FDA. She joined Division of Biological Standard and Quality Control (DBSQC), CBER, FDA where she was initially involved with the generation and calibration of reference reagents for potency assays of Influenza vaccine products. Last 6 years, she has been actively responsible in reviewing analytical procedures and their validations submitted by manufacturers in the Biological License Applications (BLAs). She is also involved in confirmatory testing of lot release assays of biological products. |